Eurobio Scientific Société anonyme (EPA:ALERS)

France flag France · Delayed Price · Currency is EUR
24.55
+0.30 (1.24%)
At close: Dec 5, 2025
-4.29%
Market Cap 247.18M
Revenue (ttm) 162.47M
Net Income (ttm) 2.36M
Shares Out 10.07M
EPS (ttm) 0.22
PE Ratio 109.40
Forward PE 31.47
Dividend n/a
Ex-Dividend Date n/a
Volume 1,414
Average Volume 603
Open 24.20
Previous Close 24.25
Day's Range 24.20 - 24.65
52-Week Range 21.80 - 26.50
Beta 0.67
RSI 46.61
Earnings Date Dec 24, 2025

About EPA:ALERS

Eurobio Scientific Société anonyme engages in the design, development, and commercialization of in vitro diagnostics products in the areas of transplantation, immunology, infectious diseases, life-science, and oncology. It commercializes media for the transportation and preservation of cornea grafts, as well as a device to facilitate the corresponding surgery; AlloMap, for heart transplant monitoring; cell culture media, molecular biology reagents, and proprietary antibodies; TQS (Tetanus Quick Stick) for the evaluation of patients’ immune stat... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1997
Employees 326
Stock Exchange Euronext Paris
Ticker Symbol ALERS
Full Company Profile

Financial Performance

In 2024, EPA:ALERS's revenue was 154.95 million, an increase of 18.60% compared to the previous year's 130.65 million. Earnings were 4.00 million, a decrease of -17.31%.

Financial Statements

News

There is no news available yet.